However, other studies reported that overexpression of STAT3 was correlated with favorable outcome of patients with breast cancer [61–65], gastric cancer [66], lung cancer [67–69], colorectal cancer [70, 71] and melanoma [72]. Here, STAT3 is linked to breast carcinoma.